(Q52234163)

27 April 2018

title

Influence of delayed viral production on viral dynamics in HIV-1 infected patients. (English)

1 reference

27 April 2018

author name string

Mittler JE

1

1 reference

27 April 2018

Sulzer B

2

1 reference

27 April 2018

Neumann AU

3

1 reference

27 April 2018

Perelson AS

4

1 reference

27 April 2018

publication date

1 September 1998

1 reference

27 April 2018

number of pages

21

1 reference

based on heuristic

inferred from page(s)

published in

Mathematical Biosciences

1 reference

27 April 2018

volume

152

1 reference

27 April 2018

page(s)

143-163

1 reference

27 April 2018

issue

2

1 reference

27 April 2018

maintained by WikiProject

WikiProject Mathematics

0 references

cites work

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

Viral dynamics in human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

The bottleneck in AZT activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

Decay characteristics of HIV-1-infected compartments during combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

Lifespan of human lymphocyte subsets defined by CD45 isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2898%2910027-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-5564(98)10027-5

1 reference

27 April 2018

PubMed ID

9780612

1 reference

27 April 2018